THYROCARENSEThyrocare Technologies LimitedMediumNeutral
Announced Tue, 23 Sept · 17:34 IST

Thyrocare Technologies Limited has informed the Exchange about Grant of Options under Thyrocare Employee Stock Option Scheme.

Business Updates View source PDF

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Thyrocare Technologies has granted 1,00,150 stock options to eligible employees of the company and its subsidiary under its Employee Stock Option Scheme. Each option is convertible into one equity share of Rs. 10 face value, at an exercise price of Rs. 10 per option. The options will vest in three equal tranches over three years, subject to vesting conditions and continued employment. Vested options can be exercised within seven years from the date of vesting. The grant was approved by the Nomination and Remuneration Committee on September 23, 2025.

Likely market impact

This is a routine employee compensation action that may lead to mild equity dilution over time, but the exercise price of Rs. 10 is very low compared to market price, signalling management confidence in long-term growth and a retention push.